Copyright
©The Author(s) 2021.
World J Diabetes. Oct 15, 2021; 12(10): 1778-1788
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1778
Published online Oct 15, 2021. doi: 10.4239/wjd.v12.i10.1778
IADPSG diagnostic criteria for GDM (2007) | ADA diagnostic criteria for T2D (2016) | |||
FBG | 2hrBG | |||
T2D (n) | Normal (n) | T2D (n) | Normal (n) | |
GDM | 65 | 202 | 1 | 33 |
Normal | 14 | 248 | 4 | 248 |
Point estimates and 95%CIs | ||||
True prevalence | 0.149 (0.12, 0.183) | 0.017 (0.006, 0.04) | ||
Sensitivity | 0.823 (0.721, 0.9) | 0.200 (0.005 0.716) | ||
Specificity | 0.551 (0.504, 0.598) | 0.883 (0.839, 0.918) | ||
Positive predictive value | 0.243 (0.193, 0.299) | 0.029 (0.001, 0.153) | ||
Negative predictive value | 0.947 (0.912, 0.97) | 0.984 (0.96, 0.996) | ||
Positive likelihood ratio | 1.833 (1.586, 2.118) | 1.703 (0.287, 10.12) | ||
Negative likelihood ratio | 0.322 (0.198, 0.521) | 0.906 (0.584, 1.408) | ||
Odds ratio | 5.7 (3.108, 10.455) | 1.879 (0.204, 17.32) |
- Citation: Bayoumi RAL, Khamis AH, Tahlak MA, Elgergawi TF, Harb DK, Hazari KS, Abdelkareem WA, Issa AO, Choudhury R, Hassanein M, Lakshmanan J, Alawadi F. Utility of oral glucose tolerance test in predicting type 2 diabetes following gestational diabetes: Towards personalized care. World J Diabetes 2021; 12(10): 1778-1788
- URL: https://www.wjgnet.com/1948-9358/full/v12/i10/1778.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i10.1778